Navigation Links
James Briscoe awarded 2008 EMBO Gold Medal
Date:7/10/2008

The European Molecular Biology Organization (EMBO) announced that James Briscoe of the Medical Research Council's National Institute for Medical Research will receive the prestigious EMBO Gold Medal for 2008.

Briscoe receives the award in recognition of his discovery that cells integrate time of exposure and concentration of a morphogen to subsequently mount a graded response.

Awarded annually, the EMBO Gold Medal recognises the outstanding contributions of young researchers in the molecular life sciences. Widely regarded as the most prestigious award of its kind in Europe, the Gold Medal highlights the high standards of Europe's best scientists.

"James Briscoe has revolutionized our understanding of the specification of cell identity in a given spatial setting," said Hermann Bujard, EMBO Executive Director. "His work exemplifies how talented scientists are advancing the field of molecular biology."

Four years at Columbia University in New York as a postdoc in Thomas Jessell's lab laid the foundation for Briscoe's career as a developmental biologist. James says he "learned" developmental biology from working alongside Jessell and a "great" postdoc in the lab at the time, Johan Ericson.

While at Columbia University, Briscoe began to unravel the control mechanisms of neuronal cell identity in the ventral neural tube a research theme sustained in his own lab at NIMR since taking up a group leader position in 2000. Specifically, the Briscoe lab studies the central role of the morphogen Sonic Hedgehog (Shh) to specify the position and subtype identity of neurons in the ventral spinal cord.

"We want to understand how neurons - nerve cells are arranged in the spinal cord," explains the EMBO Gold Medal winner for audiences other than his peers. "Specifically we are looking at the molecular basis of how different neuronal cells are organized in a developing embryo as a result of signals received from an important molecule called Sonic Hedgehog, or Shh, that is secreted from a particular region in the spinal cord."

Briscoe and his group discovered a novel mechanism that allows cells to integrate the time of exposure and the concentration of the morphogen Shh to subsequently mount a graded response. In other words, different concentrations of the morphogen activate a signal within the receiving cell for different periods of times. Cells in turn respond to different durations of the signal by activating different genes and therefore becoming different types of nerve cells.

"The discovery that concentration is effectively converted into time is a major shift in our understanding of how a graded signal acts to regulate genes," stated David Wilkinson, Head of Genetics and Development at NIMR, in his nomination of Briscoe for the EMBO Gold Medal.

James Briscoe's contribution to the understanding of how cell identity is specified in a given spatial setting has established a new paradigm that may also apply in many other contexts. In addition to Shh, a number of other secreted molecules members of different protein families have also been implicated in acting as morphogens to pattern other tissues. "It is possible that other morphogens could use a similar mechanism to control cells, for example early in embryo development during gastrulation," explains the Gold Medal winner.

"James's discoveries have revealed general principles that may apply to many other contexts in which graded signals and downstream transcription factors control cell identity," confirmed David Wilkinson.

Robb Krumlauf, former Head of Division at NIMR who helped to recruit Briscoe to the institute, points out his outstanding qualities at the bench: "At NIMR James rapidly established an independent and creative line of research in his own group. His work is highly rigorous, hits the heart of a problem, and continues to be timely and of wide general interest."

Jim Smith of the Gurdon Institute agrees with Krumlauf that Briscoe's work "has been remarkably creative and imaginative while retaining characteristic levels of careful experimentation and scholarship."

On hearing the news of the EMBO Gold Medal Briscoe referred to the success of his team of researchers: "I have been very fortunate working with very talented and smart people. They taught me a lot, supported me fantastically, and made many significant contributions."

In 2000, James Briscoe was selected to benefit from the highly competitive EMBO Young Investigator Programme, then in its first year and now renowned for its scientific excellence.

James Briscoe will receive the EMBO Gold Medal and an award of 10,000 euro on 6 September 2008 at the EMBO Members Workshop, Frontiers of Molecular Biology, in Tampere, Finland.


'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. NASA scientist James Hansen to speak at July 11 conference on Rejuvenating Public Sector Science
2. 12 McGill researchers awarded Canada Research Chairs
3. Anthony S. Fauci awarded Lasker Award for Public Service
4. ETH Zurich professor Ari Helenius awarded Benoist Prize
5. Nanobiosym awarded $2 million DTRA contract
6. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
7. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
8. $2.7 million awarded for metastatic colon cancer research
9. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
10. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
11. University awarded £5M to investigate how cells communicate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology: